The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 9 rounds in the feed, most often at Series D+ and in Healthtech.
A dedicated venture capital investment platform driving health care innovation and digital disruption forward.
Corporate venture armcvshealthventures.comRounds from 2023-10-26 to 2026-10-20
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Baba Care An applied AI company modernizing the Medicare and Medicaid experience | Series A Verified against 4 of 44 sources | $40M | 2026-10-20 | [ PART ] |
Abby Care An AI-native home care startup that trains family members to become certified, paid caregivers and supports them thereafter. | Series C Verified against 4 of |
| $82M |
| 2026-10-15 |
| [ PART ] |
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series E Verified against 4 of 8 sources | $125M | 2026-09-02 | [ PART ] |
Simile Creator of synthetic users for consumer research | Series B Verified against 1 of 11 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $200M | 2026-07-30 | [ PART ] |
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $97M | 2025-09-25 | [ PART ] |
AbsoluteCare AbsoluteCare goes beyond medicine™ to provide health plan members with care that addresses their physical, behavioral, and social needs. | Funding round Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $135M | 2025-07-22 | [ PART ] |
Abridge Abridge sells an AI-powered clinical documentation platform for healthcare professionals, enhancing the accuracy and efficiency of patient interactions and documentation. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $250M | 2025-02-17 | [ PART ] |
Abridge Abridge sells an AI-powered clinical documentation platform for healthcare professionals, enhancing the accuracy and efficiency of patient interactions and documentation. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2024-02-23 | [ PART ] |
Abridge Abridge sells an AI-powered clinical documentation platform for healthcare professionals, enhancing the accuracy and efficiency of patient interactions and documentation. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2023-10-26 | [ PART ] |